COMMD10 and gastric adenocarcinoma: Our subsequent analyses both for OS, progression-free survival of disease, and comparison of survival rates in different subgroups revealed that patients with high COMMD10 expression had lower survival rates, and that high COMMD10 expression was an independent risk factor for OS of STAD patients.